US Exchange Filings

Biofrontera Receives Nasdaq Notice, Has 180 Days to Regain Minimum-Bid Compliance

Biofrontera has until May 17, 2027, to keep its share price at or above $1 for 10 consecutive business days after 30 days below that mark. Trading remains unchanged for now, but missing the deadline could put its Nasdaq listing at risk.

Biofrontera has 180 days to bring its share price back into compliance with Nasdaq’s minimum-bid requirement. The notice does not immediately affect trading in the company’s shares, but failure to meet the threshold could put its Nasdaq listing at risk.

  • Nasdaq notified Biofrontera on November 16 that its common stock had closed below $1 for 30 consecutive business days, violating the exchange’s continued-listing standard.
  • The company has until May 17, 2027, to regain compliance. Its closing bid price must be at least $1 for a minimum of 10 consecutive business days during that period.
  • Biofrontera says it will monitor the share price and consider options to address the deficiency. It did not specify what steps it might take.
  • If Biofrontera does not meet the requirement by the deadline, it may qualify for a second compliance period if it meets other Nasdaq standards and tells the exchange it intends to cure the shortfall. A reverse stock split is one possible measure mentioned in the applicable rules.
  • Nasdaq could move toward delisting if it concludes the company cannot remedy the deficiency or Biofrontera fails other listing requirements. The company would have the opportunity to appeal a delisting decision.

The notice does not currently change the listing or trading status of Biofrontera’s securities. The company said there is no assurance it will regain compliance or maintain compliance with Nasdaq’s other requirements.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.